Impact of the US Food and Drug Administration’s safety-related announcements on the use of bisphosphonates after hip fracture

The U.S. FDA issued several announcements related to potential risk of bisphosphonates including osteonecrosis of the jaw (2005), atrial fibrillation (2007) and atypical femur fracture (2010). We aimed to evaluate the impact of three FDA drug safety announcements on the use of bisphosphonates in pat...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Bone Miner Res
Asıl Yazarlar: Kim, Seoyoung C., Kim, Dae Hyun, Mogun, Helen, Eddings, Wesley, Polinski, Jennifer M., Franklin, Jessica M., Solomon, Daniel H
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5040596/
https://ncbi.nlm.nih.gov/pubmed/26969902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.2832
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller